Alder Bio stock: buy or sell?
October 21st, 2019
Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States, Australia, and Ireland.
Should I buy Alder Bio stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Just 1 of our buy setups matches with Alder Bio stock now:
|New all-time high||No|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Alder Bio stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we gathered 10 ratings published for ALDR stock in the last 30 days.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-9-17||Credit Suisse Group||n/a||Neutral|
|2019-9-16||Needham & Company LLC||Buy||Hold|
|2019-9-16||Morgan Stanley||Underweight||Equal Weight|
|2019-9-16||BMO Capital Markets||Outperform||Market Perform|
|2019-7-10||Credit Suisse Group||n/a||Neutral|
Alder Bio stock analysis
Shares of Alder BioPharmaceuticals ended on October at $18.88 and stayed constant an unpleasant -0.21%.
Alder BioPharmaceuticals shares stayed steady -0.21% to $18.88 on October. Since price and SMA200d lines crossed up on September, ALDR climbed $8.82 (87.67%). Since last September when SMA50d and SMA100d crossed up, ALDR price gained $0.07 per share (0.37%).
Alder Bio stayed stable a tight -0.21% this week. By mid September ALDR boosted an exceptional 46.03% in just one week.
Since mid September when ALDR stock price broke up the SMA40w line, it gained $8.82 (87.67%).
Alder Bio stock price history
Alder Bio IPO was on May 8th, 2014 at $10.35 per share1. Since then, ALDR stock surged a 82.40%, with a yearly average of 16.50%. If you had invested $1,000 in Alder Bio stock in 2014, it would worth $824.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Alder Bio stock historical price chart
ALDR stock reached 52-week highs on October at $19.12, and all-time highs 2015-07-01 with a price of 54.9.
Alder Bio stock price target is $18.10Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' ALDR stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 5 price forecasts for ALDR stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-9-17||Credit Suisse Group||Reiterates||$11.00||$19.00||72.7%|
|2019-3-14||Canaccord Genuity||Lowers Target||$21.00||$20.00||-4.8%|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, Alder Bio presented its financial report, posting a pretty good growth for the Earnings per Share (EPS) ratio. Analyst expected $-1.01 per share, but Alder Bio posted $-1.19.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2017, Alder BioPharmaceuticals annual sales boosted an astounding 1,332.74% to $1.62 M USD from $0.11 marked in 2016. Likewise, its earnings margin (compared to sales) rocketed to -17,843.05%, that is $-288.88 million.
|2013||$19 M||-||$-20.61 M-109.6%||-|
|2014||$55 M||190.98%||$8.91 M16.3%||-143.22%|
|2016||$0.11 M||-99.79%||$-156.25 M-138277.9%||-1,854.09%|
|2017||$1.62 M||1,332.74%||$-288.88 M-17843.1%||84.88%|
Quarterly financial resultsReported quarter income marked $-80.09 M with a profit margin of . Profit margin remained constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, Alder BioPharmaceuticals sales marked a scary decrease and plummed a -100.00%. Looking back to recent quarterly results, Alder BioPharmaceuticals posted 4 negative quarters in a row.
|2017-Q2||$0.68 M||-||$-74.63 M-10926.8%||-|
|2017-Q4||$0.94 M||37.04%||$-54.36 M-5807.4%||-27.16%|
Alder Bio ownershipWhen you are planning to buy shares of a stock, it's worth to review its ownership structure.
Alder BioPharmaceuticals shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a of all shares.
For a better context understanding, the following table shows ownership data compared to other related stocks:
|Market cap||$0.0 M|
|Total shares||0.0 M|
|Float shares||0.0 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
Alder Bio summary
|Monday, October 21st, 2019|
|Day range||$18.83 - $19.12|
|Average true range||$0.09|
|50d mov avg||$14.21|
|100d mov avg||$12.57|
|200d mov avg||$12.67|
Alder Bio performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare Alder Bio to :